Insmed Incorporated (INSM) stock is skyrocketing as high as 110% in Tuesday's trading following positive results in the pharmaceutical company's study into treating chronic lung condition bronchiectasis. Market Domination Hosts Julie Hyman and Josh Lipton monitor Insmed's soaring stock price as it hopes to develop a range of use cases for a multitude of diseases. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
"It hurts Brittany to read comments about her son's well-being," a source tells PEOPLE
Under the agreement, Albert Bassett is ordered to complete 10 years probation, is barred from supervised contact with minors and must stay away from the victim.